Trader consensus at 74.5% for "No" stems from the CDC's ongoing absence of any Level 4 Travel Health Notices—"Avoid All Travel"—as of mid-April 2026, with no Level 3 alerts either. Recent developments, including a March 24 Level 2 notice for meningococcal disease in the Democratic Republic of the Congo's Mangembo Health Zone and a March 9 global polio advisory covering over 30 countries like Pakistan and Nigeria, highlight circulating poliovirus and outbreaks but emphasize mitigable risks via vaccination and precautions rather than extreme threats. Similarly, chikungunya and yellow fever surges in Venezuela and elsewhere remain at Level 2, while global measles and dengue are Level 1. Level 4 criteria demand uncontrollable epidemics posing substantial traveler risk despite measures, a rarity absent in current epidemiological data; ongoing CDC surveillance through year-end could reveal shifts from unforeseen outbreaks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoIl CDC emette un avviso di livello 4 entro il 31 dicembre?
Il CDC emette un avviso di livello 4 entro il 31 dicembre?
Sì
$69,767 Vol.
$69,767 Vol.
31 dic 2026
Sì
$69,767 Vol.
$69,767 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 74.5% for "No" stems from the CDC's ongoing absence of any Level 4 Travel Health Notices—"Avoid All Travel"—as of mid-April 2026, with no Level 3 alerts either. Recent developments, including a March 24 Level 2 notice for meningococcal disease in the Democratic Republic of the Congo's Mangembo Health Zone and a March 9 global polio advisory covering over 30 countries like Pakistan and Nigeria, highlight circulating poliovirus and outbreaks but emphasize mitigable risks via vaccination and precautions rather than extreme threats. Similarly, chikungunya and yellow fever surges in Venezuela and elsewhere remain at Level 2, while global measles and dengue are Level 1. Level 4 criteria demand uncontrollable epidemics posing substantial traveler risk despite measures, a rarity absent in current epidemiological data; ongoing CDC surveillance through year-end could reveal shifts from unforeseen outbreaks.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercato aperto: Jan 19, 2026, 3:15 PM ET
Volume
$69,767Data di fine
31 dic 2026Mercato aperto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 74.5% for "No" stems from the CDC's ongoing absence of any Level 4 Travel Health Notices—"Avoid All Travel"—as of mid-April 2026, with no Level 3 alerts either. Recent developments, including a March 24 Level 2 notice for meningococcal disease in the Democratic Republic of the Congo's Mangembo Health Zone and a March 9 global polio advisory covering over 30 countries like Pakistan and Nigeria, highlight circulating poliovirus and outbreaks but emphasize mitigable risks via vaccination and precautions rather than extreme threats. Similarly, chikungunya and yellow fever surges in Venezuela and elsewhere remain at Level 2, while global measles and dengue are Level 1. Level 4 criteria demand uncontrollable epidemics posing substantial traveler risk despite measures, a rarity absent in current epidemiological data; ongoing CDC surveillance through year-end could reveal shifts from unforeseen outbreaks.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$69,767Data di fine
31 dic 2026Mercato aperto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus at 74.5% for "No" stems from the CDC's ongoing absence of any Level 4 Travel Health Notices—"Avoid All Travel"—as of mid-April 2026, with no Level 3 alerts either. Recent developments, including a March 24 Level 2 notice for meningococcal disease in the Democratic Republic of the Congo's Mangembo Health Zone and a March 9 global polio advisory covering over 30 countries like Pakistan and Nigeria, highlight circulating poliovirus and outbreaks but emphasize mitigable risks via vaccination and precautions rather than extreme threats. Similarly, chikungunya and yellow fever surges in Venezuela and elsewhere remain at Level 2, while global measles and dengue are Level 1. Level 4 criteria demand uncontrollable epidemics posing substantial traveler risk despite measures, a rarity absent in current epidemiological data; ongoing CDC surveillance through year-end could reveal shifts from unforeseen outbreaks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti